Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of eribulin versus dacarbazine in advanced soft tissue sarcoma
RBR-5cmkthPhase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eribulin, dacarbazine in soft tissue sarcoma (STS), Liposarcoma, leiomyosarcoma (LMS), sponsored by Eisai Co., Ltd.. Started Mar 2011; status: completed.
02
Drugs
eribulindacarbazine
03
Conditions
soft tissue sarcoma (STS)Liposarcomaleiomyosarcoma (LMS)
Beyond the preview
Go deeper on RBR-5cmkth.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5cmkth.